Publications by authors named "Natalia Colomar-Carando"

Natural killer (NK) cell-based adoptive immunotherapy in leukemia patients is an emerging field of interest based on clinical evidence of efficacy and safety. Elderly acute myeloid leukemia (AML) patients have been successfully treated with NK cells from HLA-haploidentical donors, especially when high amounts of alloreactive NK cells were infused. The aim of this study was comparing two approaches to define the size of alloreactive NK cells in haploidentical donors for AML patients recruited in two clinical trials with the acronym "NK-AML" (NCT03955848), and "MRD-NK".

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the identification of different subsets of NK cells and their KIR gene repertoire, highlighting the importance of KIR in disease studies.
  • The monoclonal antibody HP-DM1 was confirmed to be specific for KIR2DL1, helping researchers accurately identify NK cells in potential donors for hematopoietic stem cell transplants.
  • Functional tests demonstrated that HP-DM1 can inhibit KIR2DL1's recognition of specific HLA-C types, making it a valuable tool for exploring KIR NK cell subsets.
View Article and Find Full Text PDF

Natural killer (NK) cells represent a promising cell type in antitumor immunotherapy for efficacy and safety, particularly in the treatment of hematologic malignancies. NK cells have been shown to exert antileukemia activity in the context of haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Products have been developed to boost the activation of NK cells only when cross-linked by tumor cells, avoiding any off-target effect.

View Article and Find Full Text PDF

NK cells can exert remarkable graft-versus-leukemia (GvL) effect in HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Here, we dissected the NK-cell repertoire of 80 pediatric acute leukemia patients previously reported to have an excellent clinical outcome after αβT/B-depleted haplo-HSCT. This graft manipulation strategy allows the co-infusion of mature immune cells, mainly NK and γδT cells, and hematopoietic stem cells (HSCs).

View Article and Find Full Text PDF

Zinc deficiency causes immune dysfunction. In T lymphocytes, hypozincemia promotes thymus atrophy, polarization imbalance, and altered cytokine production. Zinc supplementation is commonly used to boost immune function to prevent infectious diseases in at-risk populations.

View Article and Find Full Text PDF